Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Amsterdam

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Cardiovascular Surgery|July 1, 1988
Tube graft replacement of abdominal aortic aneurysm: is concomitant iliac disease a contraindication?J Lavee, J Schneiderman, A Bass, et al.
Circulation|January 1, 1983
Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectorisA Kimchi, G Lee, E Amsterdam, et al.
QJM : Monthly Journal of the Association of Physicians|October 31, 2013
Takotsubo cardiomyopathy associated with opiate withdrawalA Sarcon, J-R Ghadri, G Wong, et al.
The American Journal of Medicine|July 1, 1981
Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspectiveN A Awan, K E Needham, M K Evenson, et al.
Circulation|March 1, 1973
Paradoxic phenomenon of premature beats with narrow QRS in the presence of bundle-branch blockR A Massumi, G Hilliard, A DeMaria, et al.
Annals of Internal Medicine|March 1, 1994
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrateU Thadani, C R Maranda, E Amsterdam, et al.
Circulation|January 1, 1981
Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failureN A Awan, M K Evenson, K E Needham, et al.
Circulation|January 5, 2000
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group IIS C Smith, E Amsterdam, G J Balady, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Cardiovascular Surgery|July 1, 1988
Tube graft replacement of abdominal aortic aneurysm: is concomitant iliac disease a contraindication?J Lavee, J Schneiderman, A Bass, et al.
Circulation|January 1, 1983
Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectorisA Kimchi, G Lee, E Amsterdam, et al.
QJM : Monthly Journal of the Association of Physicians|October 31, 2013
Takotsubo cardiomyopathy associated with opiate withdrawalA Sarcon, J-R Ghadri, G Wong, et al.
The American Journal of Medicine|July 1, 1981
Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspectiveN A Awan, K E Needham, M K Evenson, et al.
Circulation|March 1, 1973
Paradoxic phenomenon of premature beats with narrow QRS in the presence of bundle-branch blockR A Massumi, G Hilliard, A DeMaria, et al.
Annals of Internal Medicine|March 1, 1994
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrateU Thadani, C R Maranda, E Amsterdam, et al.
Circulation|January 1, 1981
Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failureN A Awan, M K Evenson, K E Needham, et al.
Circulation|January 5, 2000
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group IIS C Smith, E Amsterdam, G J Balady, et al.
Pageof 3